In recent years, treatment outcomes of esophageal cancer have been improved by using surgical treatment, chemotherapy, and radiation therapy in combination. In our department, cooperating with the departments of Surgery, Gastrointestinal Oncology and Radiation Oncology, we provide optimal treatment according to the progress of patients’ disease. For esophageal cancer of stage II and Ⅲ, we work to improve their treatment outcomes by performing preoperative chemotherapy. In addition, we practice comprehensive treatment that takes the patient’s social background into consideration. Of early gastric cancers, mucosal cancer is treated by endoscopy with the Department of Gastroenterology, and other early gastric cancer is by laparoscopic surgery. Laparoscopic surgery responds to all types of surgical procedures including pylorus side gastrectomy, pyloric preservation gastrectomy, cardia side gastrectomy, and gastrectomy. By positively introducing laparoscopic surgery, we try to reduce the postoperative pain of patients, shorten the length of hospital stay, and return to society at an early stage. On the other hand, for highly advanced cancer, performing preoperative chemotherapy in cooperation with the Department of Gastroenterology (Gastrointestinal Oncology), and we strive to reduce the tumor and downstage, improving treatment outcomes. We aim to perform safe and reliable surgery according to the patient’s age and condition, and to reduce postoperative complications through detailed postoperative management.
Including esophageal cancer, esophageal submucosal tumor, gastric cancer, gastric cancer with remnant stomach, gastric submucosal tumor, any tumor that occurs in the upper gastrointestinal tract (esophagus, stomach) is targeted.